Kim et al.[81] found that loss of function of the glycan sulfating enzyme NDST1 targeted to antigen-presenting cells (APCs) may enhance acquired anti-tumor T cell immunity, inhibiting early KRAS-mutant lung neoplasia. This evidence concerns the gene NDST1 and neoplasm.